Correlation Between Mobivity Holdings and Integrated Biopharma

Can any of the company-specific risk be diversified away by investing in both Mobivity Holdings and Integrated Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mobivity Holdings and Integrated Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Mobivity Holdings and Integrated Biopharma, you can compare the effects of market volatilities on Mobivity Holdings and Integrated Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mobivity Holdings with a short position of Integrated Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mobivity Holdings and Integrated Biopharma.

Diversification Opportunities for Mobivity Holdings and Integrated Biopharma

0.04

Correlation Coefficient

Mobivity Holdings  Integrated Biopharma

Significant diversification

The 3 months correlation between Mobivity and Integrated is 0.04. Overlapping area represents the amount of risk that can be diversified away by holding Mobivity Holdings and Integrated Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Integrated Biopharma and Mobivity Holdings is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mobivity Holdings are associated (or correlated) with Integrated Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Integrated Biopharma has no effect on the direction of Mobivity Holdings i.e., Mobivity Holdings and Integrated Biopharma go up and down completely randomly.

Pair Corralation between Mobivity Holdings and Integrated Biopharma

If you would invest  30.00  in Mobivity Holdings on September 5, 2024 and sell it today you would lose (2.00) from holding Mobivity Holdings or give up 6.67% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	1.56%
Values	Daily Returns

Mobivity Holdings  vs.  Integrated Biopharma

Mobivity Holdings

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Mobivity Holdings are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of very abnormal basic indicators, Mobivity Holdings displayed solid returns over the last few months and may actually be approaching a breakup point.

Integrated Biopharma

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Integrated Biopharma has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable fundamental drivers, Integrated Biopharma is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.

Pair Trading with Mobivity Holdings and Integrated Biopharma

The main advantage of trading using opposite Mobivity Holdings and Integrated Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mobivity Holdings position performs unexpectedly, Integrated Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Integrated Biopharma will offset losses from the drop in Integrated Biopharma's long position.

The idea behind Mobivity Holdings and Integrated Biopharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.